• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子XI苹果1结构域中凝血酶的结合位点。

A binding site for thrombin in the apple 1 domain of factor XI.

作者信息

Baglia F A, Walsh P N

机构信息

Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

出版信息

J Biol Chem. 1996 Feb 16;271(7):3652-8. doi: 10.1074/jbc.271.7.3652.

DOI:10.1074/jbc.271.7.3652
PMID:8631976
Abstract

Previously we defined a binding site for high molecular weight kininogen (HK) in the A1 domain of factor XI (FXI). Since thrombin can activate FXI and HK inhibits the activation of FXI by thrombin, we have identified a thrombin binding site in FXI. Both the recombinant A1 domain (Glu1-Ser90) and a synthetic peptide (Phe56-Ser86) containing the HK binding site inhibited FXI activation by thrombin. Both a monoclonal antibody, 5F7, recognizing the A1 domain, and the rA1 domain were shown to be competitive inhibitors of thrombin-catalyzed FXI activation. The peptides Ala45-Arg54 and Val59-Arg70 acted synergistically to inhibit FXI activation by thrombin. Mutant rA1 domain constructs (Val64 --> Ala and Ile77 --> Ala), which do not inhibit FXI binding to HK, retain full capacity to inhibit FXI activation by thrombin. The peptide Ala45-Arg54 inhibited thrombin-catalyzed FXI activation, whereas it had no effect on FXI binding to HK. In contrast, the peptide Asn72-Leu83 (which inhibited FXI binding to HK) did not inhibit FXI activation by thrombin. Thus, a thrombin binding site exists in the A1 domain of FXI spanning residues Ala45-Arg70 that is contiguous with but separate and distinct from the HK binding site. These sites may regulate which ligand is bound to FXI and through which pathway FXI is activated.

摘要

此前我们在因子 XI(FXI)的 A1 结构域中定义了一个高分子量激肽原(HK)的结合位点。由于凝血酶可激活 FXI,且 HK 抑制凝血酶对 FXI 的激活,我们在 FXI 中鉴定出了一个凝血酶结合位点。重组 A1 结构域(Glu1 - Ser90)和包含 HK 结合位点的合成肽(Phe56 - Ser86)均抑制凝血酶对 FXI 的激活。识别 A1 结构域的单克隆抗体 5F7 和 rA1 结构域均被证明是凝血酶催化的 FXI 激活的竞争性抑制剂。肽段 Ala45 - Arg54 和 Val59 - Arg70 协同作用抑制凝血酶对 FXI 的激活。不抑制 FXI 与 HK 结合的突变型 rA1 结构域构建体(Val64 --> Ala 和 Ile77 --> Ala)保留了完全抑制凝血酶激活 FXI 的能力。肽段 Ala45 - Arg54 抑制凝血酶催化的 FXI 激活,而对 FXI 与 HK 的结合无影响。相反,肽段 Asn72 - Leu83(抑制 FXI 与 HK 的结合)不抑制凝血酶对 FXI 的激活。因此,在 FXI 的 A1 结构域中存在一个凝血酶结合位点,其跨越 Ala45 - Arg70 残基,与 HK 结合位点相邻但分开且不同。这些位点可能调节哪个配体与 FXI 结合以及 FXI 通过哪条途径被激活。

相似文献

1
A binding site for thrombin in the apple 1 domain of factor XI.凝血因子XI苹果1结构域中凝血酶的结合位点。
J Biol Chem. 1996 Feb 16;271(7):3652-8. doi: 10.1074/jbc.271.7.3652.
2
A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XI.凝血因子XI苹果1结构域中凝血酶原kringle II结构域的结合位点。
J Biol Chem. 2000 Oct 13;275(41):31954-62. doi: 10.1074/jbc.M005465200.
3
Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.高分子量激肽原与因子XI的苹果1结构域的结合部分由缬氨酸64和异亮氨酸77介导。
Biochem J. 1994 Dec 15;304 ( Pt 3)(Pt 3):715-21. doi: 10.1042/bj3040715.
4
The Apple 1 and Apple 4 domains of factor XI act synergistically to promote the surface-mediated activation of factor XI by factor XIIa.
Blood. 1995 Apr 15;85(8):2078-83.
5
Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.凝血因子XI上H-激肽原结合位点的特征:凝血因子XI与血浆前激肽释放酶的比较。
J Biol Chem. 2002 Feb 15;277(7):4892-9. doi: 10.1074/jbc.M105221200. Epub 2001 Nov 30.
6
Thrombin activation of the factor XI dimer is a multistaged process for each subunit.凝血酶激活因子 XI 二聚体是一个多阶段的过程,每个亚基都参与其中。
J Thromb Haemost. 2024 May;22(5):1336-1346. doi: 10.1016/j.jtha.2023.12.038. Epub 2024 Jan 17.
7
Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.凝血酶原是因子 XI 与血小板表面结合以及凝血酶介导血小板激活因子 XI 过程中的一种辅助因子。
Biochemistry. 1998 Feb 24;37(8):2271-81. doi: 10.1021/bi972113+.
8
Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.骨骼肌肌球蛋白通过其 A3 结构域与因子 XI 结合并增强凝血酶诱导的因子 XI 激活,从而促进凝血。
J Biol Chem. 2022 Feb;298(2):101567. doi: 10.1016/j.jbc.2022.101567. Epub 2022 Jan 7.
9
Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet.凝血因子XI与活化血小板上糖蛋白Ibalpha的富含亮氨酸重复序列相互作用。
J Biol Chem. 2004 Nov 19;279(47):49323-9. doi: 10.1074/jbc.M407889200. Epub 2004 Sep 16.
10
The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.前激肽释放酶与因子XI/XIa在培养内皮细胞上组装的相对优先级。
J Biol Chem. 2003 Nov 7;278(45):43983-90. doi: 10.1074/jbc.M304239200. Epub 2003 Aug 27.

引用本文的文献

1
Factor XI and Atrial Fibrillation: A Mismatched Pairing?因子XI与心房颤动:不匹配的组合?
Eur Cardiol. 2025 Apr 10;20:e08. doi: 10.15420/ecr.2024.61. eCollection 2025.
2
Biology of factor XI.因子 XI 的生物学。
Blood. 2024 Apr 11;143(15):1445-1454. doi: 10.1182/blood.2023020719.
3
Kininogen debuts on apple (domain) disks.激肽原在苹果(结构域)盘上首次出现。
J Thromb Haemost. 2023 Sep;21(9):2370-2372. doi: 10.1016/j.jtha.2023.05.013.
4
Discovery of Teleost Plasma Kallikrein/Coagulation Factor XI-Like Gene from Channel Catfish (Ictalurus punctatus) and the Evidence that the Protein Encoded by it Acts as a Lectin.从斑点叉尾鮰(Ictalurus punctatus)中发现硬骨鱼血浆 Kallikrein/凝血因子 XI 样基因,并证明其编码蛋白具有凝集素活性。
J Mol Evol. 2023 Aug;91(4):536-551. doi: 10.1007/s00239-023-10113-4. Epub 2023 May 8.
5
BJTJ-1837, a novel FXI activation-blocking antibody.BJTJ - 1837,一种新型的抑制凝血因子XI激活的抗体。
Res Pract Thromb Haemost. 2023 Feb 7;7(2):100067. doi: 10.1016/j.rpth.2023.100067. eCollection 2023 Feb.
6
Structural insights into the activation of blood coagulation factor XI zymogen by thrombin: A computational molecular dynamics study.凝血因子 XI 酶原激活的结构洞察:计算分子动力学研究。
Biophys Chem. 2022 Feb;281:106737. doi: 10.1016/j.bpc.2021.106737. Epub 2021 Dec 14.
7
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present).因子 XI(a)抑制剂治疗血栓:更新的专利审查(2016 年至今)。
Expert Opin Ther Pat. 2020 Jan;30(1):39-55. doi: 10.1080/13543776.2020.1705783. Epub 2019 Dec 19.
8
Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.血浆激肽释放酶结构揭示与因子 XI 相比,苹果域盘旋转构象。
J Thromb Haemost. 2019 May;17(5):759-770. doi: 10.1111/jth.14418. Epub 2019 Mar 19.
9
Recent advances in the discovery and development of factor XI/XIa inhibitors.近年来,因子 XI/XIa 抑制剂的发现和开发取得了新进展。
Med Res Rev. 2018 Sep;38(6):1974-2023. doi: 10.1002/med.21503. Epub 2018 May 4.
10
An update on factor XI structure and function.因子 XI 结构与功能的最新研究进展。
Thromb Res. 2018 Jan;161:94-105. doi: 10.1016/j.thromres.2017.10.008. Epub 2017 Oct 10.